FDA official logo
GSRS logo
PFDA official logo

YTTRIUM Y-90 CLIVATUZUMAB TETRAXETAN

  • UNII: 2L271110ED
  • Preferred Substance Name: YTTRIUM Y-90 CLIVATUZUMAB TETRAXETAN

  • 943976-23-6
  • 90HY-PAM4
  • 90Y-HPAM4
  • 90Y-HPAMA4
  • CONJ:MAB HUMANIZED (IGG1) ANTI P15941 (MUC1_HUMAN); YTTRIUM Y 90 (IMMU107)
  • HPAM4-DOTA
  • HPAM-4-DOTA
  • IMMU-107
  • IMMUNOGLOBULIN G1, ANTI-(HUMAN MUCIN MUC1) (HUMAN-MOUSE MONOCLONAL HPAM4 HEAVY CHAIN), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL HPAM4 .KAPPA.-CHAIN, DIMER, 1,4,7,10-TETRAAZACYCLODODECANE-1,4,7,10-TETRAACETIC ACID CONJUGATE, YTTRIUM-SUP(90)Y CHELATE
  • IMMUNOGLOBULIN G1, ANTI-(HUMAN MUCIN MUC1) (HUMAN-MOUSE MONOCLONAL HPAM4 HEAVY CHAIN), DISULPHIDE WITH HUMAN-MOUSE MONOCLONAL HPAM4 .KAPPA.-CHAIN, DIMER, 1,4,7,10-TETRAAZACYCLODODECANE-1,4,7,10-TETRAACETIC ACID CONJUGATE, YTTRIUM-SUP(90)Y CHELATE
  • PAN-CIDE
  • S9S0HY-PAM4
  • Y-90 HPAM4
  • YTTRIUM (90Y) CLIVATUZUMAB TETRAXETAN
  • YTTRIUM (90Y) CLIVATUZUMAB TETRAXETAN [INN]
  • YTTRIUM Y 90 CLIVATUZUMAB TETRAXETAN
  • YTTRIUM Y 90 CLIVATUZUMAB TETRAXETAN [USAN]

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.